Clinical trials
Phase 3 Purpura, Thrombocytopenic, Idiopathic trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong University | 5 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 1 |
| Peking Union Medical College | 1 |
| Seoul National University Hospital | 1 |
| Unity Health Toronto | 1 |
| Yin Jie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 12 |
| Thrombocytopenia | 4 |
| Hemorrhage | 1 |
| Lymphoma, Follicular | 1 |
| Purpura | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.